Diazepam Tablets BP 5 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Diazepam Tablets BP 5 mg | Manufacturer
Product image for Diazepam Tablets BP 5 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Diazepam |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049081 |
| Pharmacopoeia | BP |
| Product Type | Tablet |
| Category | Anxiolytic and Sedative drugs |
| Subcategory | Anxiolytic and Sedative drugs |
| Active Ingredient | Diazepam |
| Strength | 5 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Anxiolytic and Sedative drugs |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Diazepam Tablets BP 5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Acute and maintenance treatment of schizophrenia and related psychotic disorders. 2. Bipolar I disorder mania, mood stabilization, and severe behavioral agitation. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Diazepam Tablets BP 5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Diazepam Tablets BP 5 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Diazepam Tablets BP 5 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Diazepam Tablets BP 5 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally once or twice daily, with or without food. Titrate gradually from a low initial dose under close psychiatric supervision. Do not discontinue therapy abruptly. | ||||||||||||||||||||||||
| Side Effects | Common: Somnolence, sedation, dry mouth, weight gain, constipation, mild dizziness. Uncommon: Extrapyramidal symptoms, orthostatic hypotension, akathisia, elevated prolactin. Rare: Neuroleptic malignant syndrome, tardive dyskinesia, agranulocytosis (with clozapine). | ||||||||||||||||||||||||
| Warnings and Precautions | Metabolic Monitoring: Regularly check fasting blood glucose, lipid profiles, and body weight. Hematologic & ECG Monitoring: Periodic complete blood counts and ECGs are indicated during chronic therapy. Sedation & Driving: Avoid driving or operating machinery until individual tolerance is established. | ||||||||||||||||||||||||
| Contraindications | 1. Hypersensitivity to Diazepam or related psychotropic derivatives. 2. Severe central nervous system depression, comatose states, or severe bone marrow suppression. 3. Uncontrolled epilepsy or history of severe blood dyscrasias. | ||||||||||||||||||||||||
| Drug Interactions | 1. CNS Depressants & Alcohol: Potentiated sedation, psychomotor slowing, and respiratory depression. 2. Antihypertensives: Synergistic orthostatic hypotensive effects. 3. CYP Enzymes: Inhibitors (fluoxetine, ketoconazole) increase antipsychotic levels; inducers decrease efficacy. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Diazepam Tablets BP 5 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Diazepam Tablets BP 5 mg? | The source specification is BP; confirm the required standard before contracting. |
| What quality tests are applicable for Diazepam Tablets BP 5 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Diazepam Tablets BP 5 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Diazepam Tablets BP 5 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Diazepam Tablets BP 5 mg ExporterView product →
✚
Diazepam Tablets BP 5 mg SupplierView product →
✚
Diazepam Tablets IP 5 mg ExporterView product →
✚
Diazepam Tablets IP 5 mg ManufacturerView product →
✚
Diazepam Tablets IP 5 mg SupplierView product →
✚
Chlordiazepoxide Hydrochloride Tablets BP 10 mg ExporterView product →
✚
Chlordiazepoxide Hydrochloride Tablets BP 10 mg ManufacturerView product →
✚
Chlordiazepoxide Hydrochloride Tablets BP 10 mg SupplierView product →
✚
Lorazepam Tablets BP 1 mg ExporterView product →
✚
Lorazepam Tablets BP 1 mg ManufacturerView product →
✚
Lorazepam Tablets BP 1 mg SupplierView product →
✚
Lorazepam Tablets IP 2 mg ExporterView product →
